Iconix Pharmaceuticals Announces Publication of Key Biomarker/Drug Signature Paper in Genome Research
Iconix Pharmaceuticals Announces Publication of Key Biomarker/Drug Signature Paper in Genome Research
The analysis focused on a family of new linear classification methods including Sparse Linear Programming (SPLP) and Sparse Logistic Regression (SPLR) and their performance classifying drugs in four categories
The analysis focused on a family of new linear classification methods including Sparse Linear Programming (SPLP) and Sparse Logistic Regression (SPLR) and their performance classifying drugs in four categories
posted by Roger Grinde at 7:13 PM
0 Comments:
Post a Comment
<< Home